Over the last few years, we have witnessed tremendous progress in the field of eicosanoids and their therapeutic applications. Receptor an- tagonists for leukotrienes have been tested as anti-inflammatories and are on the market as a treatment for asthma. Receptor agonists for pro- stacyclin are being tested for the treatment of peripheral vascular dis- ease, and selective inhibitors of cyclooxygenase type II were just ap- proved for the treatment of rheumatoid arthritis. All these developments are the culmination of many years and man-hours of careful research. The field has now entered an upswing that will result in novel thera- peutic applications within the next 10 years. New molecules and me- diators have been identified, new enzymes and pathways elucidated and new therapeutic approaches have emerged. The concept of ei- cosanoids as "pro-inflammatory" molecules is being challenged, and their role as regulators is increasingly recognized. In fact, some of these molecules may be important endogenous anti-inflammatory agents.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : Ammareal, Morangis, France
Hardcover. Etat : Très bon. Ancien livre de bibliothèque avec équipements. Edition 2000. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Edition 2000. Ammareal gives back up to 15% of this item's net price to charity organizations. N° de réf. du vendeur F-979-820
Quantité disponible : 1 disponible(s)
Vendeur : Bookbot, Prague, Rébublique tchèque
Hardcover. Etat : Fine. Leichte Gebrauchsspuren. Over the last few years, we have witnessed tremendous progress in the field of eicosanoids and their therapeutic applications. Receptor an tagonists for leukotrienes have been tested as anti-inflammatories and are on the market as a treatment for asthma. Receptor agonists for pro stacyclin are being tested for the treatment of peripheral vascular dis ease, and selective inhibitors of cyclooxygenase type II were just ap proved for the treatment of rheumatoid arthritis. All these developments are the culmination of many years and man-hours of careful research. The field has now entered an upswing that will result in novel thera peutic applications within the next 10 years. New molecules and me diators have been identified, new enzymes and pathways elucidated and new therapeutic approaches have emerged. The concept of ei cosanoids as ,pro-inflammatory" molecules is being challenged, and their role as regulators is increasingly recognized. In fact, some of these molecules may be important endogenous anti-inflammatory agents. N° de réf. du vendeur 498bb21b-7b86-42cb-af17-d6eeb57ee1d0
Quantité disponible : 1 disponible(s)
Vendeur : Anybook.com, Lincoln, Royaume-Uni
Etat : Good. Volume 31. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,500grams, ISBN:9783540667476. N° de réf. du vendeur 9866099
Quantité disponible : 1 disponible(s)
Vendeur : Wissenschaftl. Antiquariat Th. Haker e.K, Klettgau, Allemagne
Etat : Sehr gut. 225 p. In very good condition. ISBN: 9783540667476 Sprache: Englisch Gewicht in Gramm: 315 15,2 x 1,3 x 21,6 cm, hardcover. N° de réf. du vendeur 58283
Quantité disponible : 1 disponible(s)